|
|
|
|
Thursday's market movers including ValiRx |
|
Datum: 13/06/2013 06:52   - Genom: bambaec   - 70 Visningar   - Kategori: Olika
The firm has agreed an expanded protocol for its first-in-man studies on VAL 201 - the drug candidate being developed for prostate cancer\nLON:BAO
|
|
Kommentarer... |
|
Relaterade videor... |
|
|
|
|
|
|
|